Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

NCT00003747 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: carboplatin
DRUG: temozolomide

Sponsor

Mount Vernon Cancer Centre at Mount Vernon Hospital